Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Persistent Effect of Advanced Glycated Albumin Driving Inflammation and Disturbances in Cholesterol Efflux in Macrophages

Full text
Author(s):
Minanni, Carlos Andre [1, 2] ; Machado-Lima, Adriana [3, 1] ; Iborra, Rodrigo Tallada [1, 4] ; Okuda, Ligia Shimabukuro [1] ; Pinto, Raphael de Souza [1] ; Mello Santana, Monique de Fatima [1] ; de Araujo Lira, Aecio Lopes [1] ; Nakandakare, Edna Regina [1] ; Cardillo Correa-Giannella, Maria Lucia [5] ; Passarelli, Marisa [6, 1]
Total Authors: 10
Affiliation:
[1] Univ Sao Paulo, Lab Lipides LIM 10, Hosp Clin HCFMUSP, Fac Med, BR-01246000 Sao Paulo - Brazil
[2] Hosp Israelita Albert Einstein HIAE, BR-05652900 Sao Paulo - Brazil
[3] Univ Sao Judas Tadeu, Programa Posgrad Ciencias Envelhecimento, BR-03166000 Sao Paulo - Brazil
[4] Univ Sao Judas Tadeu, Programa Posgrad Educ Fis, BR-03166000 Sao Paulo - Brazil
[5] Univ Sao Paulo, Lab Carboidratos & Radioimunoensaio LIM 18, Hosp Clin HCFMUSP, Fac Med, BR-01246000 Sao Paulo - Brazil
[6] Univ Nove de Julho, Programa Posgrad Med, BR-01525000 Sao Paulo - Brazil
Total Affiliations: 6
Document type: Journal article
Source: NUTRIENTS; v. 13, n. 10 OCT 2021.
Web of Science Citations: 1
Abstract

Advanced glycated albumin (AGE-albumin) impairs cholesterol efflux and contributes to inflammation in macrophages. The current study evaluated: (1) the persistence of the deleterious effect of AGE-albumin in cholesterol efflux and in inflammation, and (2) how metabolic control in diabetes mellitus (DM) contributes to attenuate the deleterious role of AGE-albumin in macrophage cholesterol homeostasis. Methods: AGE-albumin was produced in vitro or isolated from uncontrolled DM subjects' serum before (bGC) and after improved glycemic control (aGC). Albumin samples were incubated with bone marrow-derived macrophages and C-14-cholesterol efflux or LPS- induced cytokine secretion were determined immediately, or after cell resting in culture media alone. The ABCA-1 degradation rate was determined after cell incubation with cycloheximide, and ABCA1 protein level by immunoblot. Oil Red O staining was used to assess intracellular lipid accumulation. Results: A persistent effect of AGE-albumin was observed in macrophages in terms of the secretion of inflammatory cytokines and reduced cholesterol efflux. HDL-mediated C-14-cholesterol efflux was at least two times higher in macrophages treated with aCG-albumin as compared to bGC-albumin, and intracellular lipid content was significantly reduced in aGC-albumin-treated cells. As compared to bGC-albumin, the ABCA-1 protein content in whole cell bulk was 94% higher in aCG-albumin. A 20% increased ABCA-1 decay rate was observed in macrophages treated with albumin from poorly controlled DM. AGE-albumin has a persistent deleterious effect on macrophage lipid homeostasis and inflammation. The reduction of AGEs in albumin ameliorates cholesterol efflux.</p> (AU)

FAPESP's process: 17/18545-4 - HDL proteomics and functionality in diabetes mellitus chronic kidney disease: association with advanced glycation end products
Grantee:Monique de Fatima Mello Santana
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 12/19112-0 - Involvement of the RAGE/AGE axis in macrophage lipid accumulation induced by human advanced glycated albumin - contribution of glycemic control in diabetes mellitus.
Grantee:Adriana Machado Saldiba de Lima
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 16/15603-0 - Unraveling mechanisms of glycemic control and chronic complications of Diabetes mellitus: contributions to human health
Grantee:Ubiratan Fabres Machado
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 12/12088-7 - Glycemic control and the removal of macrophage cholesterol by ABCA-1: role of modified albumin by advanced glycation
Grantee:Rodrigo Tallada Iborra
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 18/00172-0 - Advanced glycation products, endoplasmic reticulum stress and the modulation of the reverse cholesterol transport in human arteries with different levels Atherosclerotic lesion
Grantee:Raphael de Souza Pinto
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 15/21072-5 - Influence of the glycemic control and nephropathy stage on the reverse cholesterol transport in Diabetes mellitus: role of metabolic memory induced by advanced glycated albumin
Grantee:Marisa Passarelli
Support Opportunities: Regular Research Grants